
Back to index
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
Life Science Leader
Data Management and Information Technology—Do the Benefits Outweigh the Risks?
Life Science Leader
Advancing Sponsor/CRO Collaborations to Improve Preclinical Throughput
Life Science Leader
Not A Popularity Contest
PharmPro
Outsourcing Clinical Research: Established vs. Emerging Markets
April 2012
March 2012
February 2012
January 2012
December 2011
Pharma iQ
Overcoming Barriers to Forming Successful Relationships with CMOs in Emerging Markets
PharmPro
Who should be doing your Pharmaceutical Analytical Testing – a CRO or CMO?
Pharmaceutical Manufacturing
Rating Pharma Contract Manufacturers: Does Perception Equal Reality?
BioSpace
Nice Insight Announces Publication of Its Q4 CRO/CMO Quarterly Intelligence Report
November 2011
October 2011
Life Science Leader
Will A Focus On Innovation Pay Off For Custom Synthesis Providers?
FiercePharma Manufacturing
Top 10 Standout CMOs
BioPharm International
Contract Services Spending: Who's Spending What, and Where?
Pharmaceutical Outsouring
How Relevant are 483s in Terms of Compliance Perception?
SFGate, PRWeb
Therapure Biopharma Inc. wins The CMO Leadership Award
Life Science Leader
Social Media Leads To Editorial – And More
PharmPro
Sterile Manufacturing Oppportunities
Life Science Leader — CMO Leadership Awards supplement issue
It’s About the Customer
PharmaChem
Where do strategic business opportunities lie for mid-tier CROs?
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
NI Company News
NI Published Articles
NI Calendar of Events
NI Media Partners
Contact Us
September 16-18 Long Branch, NJ
|
|
|
Pharmaceutical Commerce
April 2011
Contact
Victor Coker Director of Business Intelligence +1 212 366 4455 ![]() ![]() ![]() ![]() ![]()
|
New market-research service hopes to quantify trends in outsourced CMOs, CROs and related services That’s Nice LLC (New York), a small full-service agency with offices worldwide, is setting up a proprietary information service that will track industry awareness of providers of contract services, to be called Marcom Tracker and Brand Index. Marcom Tracker will be of value to marketing and business development managers at CMOs and CROs, if only to track the promotional activities of their competitors. Brand Index, meanwhile, is intended to be a measure of who the major players are in specific CMO services globally, such as product formulation, lyophilization, fill & finish or packaging. “This is new,” says Nigel Walker, managing director at That’s Nice, explaining that while there are many directories or compilations of service providers, there is very little available in syndicated market research that tracks the businesses by size, reputation or customer awareness. Bio/pharma manufacturers will be able to identify key organizations by type of service, geography and other criteria. The Brand Index service will be updated quarterly. The first compilation shows that the leading brandnames among CMOs (alphabetically; the exact ranking is available only to subscribers) include: • 3M Drug Delivery Systems • Abbott • BASF • Baxter BioPharma Solutions • Baxter International • DuPont Pharmaceutical and Biopharma Manufacturing • Genzyme Pharmaceuticals • GlaxoSmithKline Pharmaceuticals • Honeywell Process Solutions • Roche Custom Biotech Victor Coker, a project manager at the That’s Nice, notes that a CMO is defined as “companies that provide services that assist in the development and commercial manufacturing of API and excipients.” Thus, Honeywell Process Automation—a process automation supplier primarily—becomes a CMO when it helps set up and run, for example, a batch management system at a client site. In this schema, conventional outsourced manufacturing, which is usually thought of as the totality of the CMO market, becomes only 30% of the companies that That’s Nice will track. Another finding of the survey is that 85% of companies score less than 40% in overall awareness, meaning that most CMOs and CROs are not well known beyond their existing customer base. “Lower awareness suggests a narrow strategic marketing focus, rather than communication to a broader prospective customer base to ensure sustainability,” says the company. The research data are compiled by monitoring and tracking promotional and business activity, as well as by compensated panels of industry professionals who will regularly be asked to rate the contract firms they are familiar with. Given the dynamic forces coursing through contract manufacturing these days, with major pharmas divesting specialized services almost weekly, even as new outsourcing providers enter from Asia, there could be meaningful insights to the trends in the industry. |






















